-
SABCS Hot Commentary:Professor Xiaoyun Mao: A Breakthrough in “Intensified” First-Line Maintenance Therapy for HER2-Positive Metastatic Breast Cancer
At the 2025 San Antonio Breast Cancer Symposium (SABCS 2025), results were presented from a study titled “HER2CLIMB-05: A Randomized, Double-Blind Phase III Study of Tucatinib versus Placebo in Combination with Trastuzumab and Pertuzumab as Maintenance Therapy for HER2-Positive Metastatic Breast Cancer” (Abstract No. GS1-01). This study explored an intensified strategy for first-line maintenance therapy…
-
The 17th Shanghai Breast Cancer Professional Symposium 丨Professor Benlong Yang: Exercising Caution in Surgical Indications for Advanced Breast Cancer and Strictly Upholding the Threshold for Prophylactic Mastectomy
Recently, the 17th Shanghai Breast Cancer Professional Symposium, held in conjunction with the Annual Meeting of the Breast Cancer Committee of the Shanghai Anti-Cancer Association and the 2026 Breast Cancer Guideline “Red Book” Update Meeting, took place in Shanghai. During the meeting, the 2026 Edition of the Essentials of the Breast Cancer Diagnosis and Treatment…
-
Prof. Jian Zhang: Precision and Innovation Driving the New “Red Book” in Breast Cancer Care in China
Editor’s Note The 17th Shanghai Breast Cancer Professional Symposium, held in conjunction with the Annual Meeting of the Breast Cancer Committee of the Shanghai Anti-Cancer Association and the 2026 Breast…
-
Professor Zefei Jiang: The Northern Breast Cancer Salon Returns
A Comprehensive Review of Annual Advances and Guideline Updates, and a Look Ahead at New Trends in Clinical Practice 丨Northern Breast Cancer Salon Editor’s Note As the year turns, another…
-
2026 CASH丨Professor Xiaofan Zhu: New Directions in Pediatric Hematologic Malignancies Through the Lens of ASH Frontiers
Editor’s Note At the beginning of the new year, distinguished experts gathered in Tianjin. From January 9 to 11, 2026, the 6th China Congress on the Advancement of Hematology (CASH)…
-
2026 CASH | Professor Jianqing Mi: Advances and Future Directions of CAR-T Cell Therapy in Multiple Myeloma
Editor’s Note At the dawn of the new year, leading experts convened in Tianjin. From January 9 to 11, 2026, the 6th China Congress on the Advancement of Hematology (CASH)…
-
2026 CASH | Professor Lugui Qiu: Annual Review of the 2025 Multiple Myeloma Guidelines
Editor’s Note At the beginning of the new year, leading experts gathered in Tianjin. From January 9 to 11, 2026, the 6th China Congress on the Advancement of Hematology (CASH)…
-
CASH 2026 | Prof. Wang Tianyou: Forty Years of Change in China’s Pediatric Disease Spectrum and Strategic Responses
With the dawn of the new year, Tianjin once again became a hub for academic exchange. From January 9 to 11, 2026, the 6th China Annual Conference on the Development of Hematology (CASH) was grandly held in Tianjin. Bringing together leading experts in hematology from China and abroad, the conference focused on disciplinary frontiers and…
Connecting Medical Expertise through Media